New Delhi, Sept. 18 -- India is widening its pharmaceutical export base across Latin America, Africa and Europe after shipments to the United States, its largest market, declined nearly 10 per cent last year, Pharmexcil Chairman Namit Joshi said, even as overall exports continued to grow amid global volatility.

Speaking on India's pharmaceutical exports and supply-chain resilience, Joshi said the decline in the US market resulted in an erosion of nearly USD 1 billion in exports.

"We have seen that our US market is declining. Last year, there was almost 10 per cent degrowth. So, almost USD 1 billion was eroded. The US is our largest trading partner in pharmaceuticals," Joshi said.

He said exports to the US declined from around USD 10.5 ...